Clinical data from the Emerge study demonstrated that a single dose of DT120 Orally Disintegrating Tablet produced significant antidepressant effects starting at week 1 that were sustained through week 12.

From the articleFDA grants breakthrough therapy designation for DT120 ODT in depression treatment